Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 26;11(11):1984.
doi: 10.3390/diagnostics11111984.

Advances in Diagnostic Bronchoscopy

Affiliations
Review

Advances in Diagnostic Bronchoscopy

Yi-Cheng Shen et al. Diagnostics (Basel). .

Abstract

The increase in incidental discovery of pulmonary nodules has led to more urgent requirement of tissue diagnosis. The peripheral pulmonary nodules are especially challenging for clinicians. There are various modalities for diagnosis and tissue sampling of pulmonary lesions, but most of these modalities have their own limitations. This has led to the development of many advanced technical modalities, which have empowered pulmonologists to reach the periphery of the lung safely and effectively. These techniques include thin/ultrathin bronchoscopes, radial probe endobronchial ultrasound (RP-EBUS), and navigation bronchoscopy-including virtual navigation bronchoscopy (VNB) and electromagnetic navigation bronchoscopy (ENB). Recently, newer technologies-including robotic-assisted bronchoscopy (RAB), cone-beam CT (CBCT), and augmented fluoroscopy (AF)-have been introduced to aid in the navigation to peripheral pulmonary nodules. Technological advances will also enable more precise tissue sampling of smaller peripheral lung nodules for local ablative and other therapies of peripheral lung cancers in the future. However, we still need to overcome the CT-to-body divergence, among other limitations. In this review, our aim is to summarize the recent advances in diagnostic bronchoscopy technology.

Keywords: bronchoscopy; endobronchial ultrasound; navigation bronchoscopy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. de Koning H.J., Meza R., Plevritis S.K., Ten Haaf K., Munshi V.N., Jeon J., Erdogan S.A., Kong C.Y., Han S.S., van Rosmalen J., et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2014;160:311–320. doi: 10.7326/M13-2316. - DOI - PMC - PubMed
    1. Park C.H., Han K., Hur J., Lee S.M., Lee J.W., Hwang S.H., Seo J.S., Lee K.H., Kwon W., Kim T.H., et al. Comparative Effectiveness and Safety of Preoperative Lung Localization for Pulmonary Nodules: A Systematic Review and Meta-analysis. Chest. 2017;151:316–328. doi: 10.1016/j.chest.2016.09.017. - DOI - PubMed
    1. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873. - DOI - PMC - PubMed
    1. Ellis P.M., VanderMeer R. Delays in the diagnosis of lung cancer. J. Thorac. Dis. 2011;3:183–188. doi: 10.3978/j.issn.2072-1439.2011.01.01. - DOI - PMC - PubMed
    1. Yousaf-Khan U., Van Der Aalst C., De Jong P.A., Heuvelmans M., Scholten E., Lammers J.-W., van Ooijen P., Nackaerts K., Weenink C., Groen H., et al. Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval. Thorax. 2017;72:48–56. doi: 10.1136/thoraxjnl-2016-208655. - DOI - PubMed

LinkOut - more resources